NCT06779760

Brief Summary

The role of near-infrared autofluorescence (NIRAF)-imaging as an adjunct in thyroid surgery is well established. However, its diagnostic role in hyperparathyroidism surgery is yet to be defined due to the lack of consensus regarding the autofluorescence (AF) pattern of pathological parathyroid glands. Furthermore, its utility via a direct minimal access has not been assessed. To assess the AF pattern of parathyroid adenomas (PAs) utilizing NIRAF-imaging in minimally invasive video-assisted parathyroidectomy (MIVAP). The clinical records of patients who underwent MIVAP for hyperparathyroidism between February and October 2024 were retrospectively reviewed. The primary endpoint was to assess the AF pattern of PAs. Secondary endpoints included the feasibility of applying NIRAF imaging in MIVAP and whether certain AF patterns of PAs correlated with cell type, size, and/or location. Furthermore, operative-time and cost implications were assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 20, 2024

Completed
25 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 15, 2024

Completed
5 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2024

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

November 3, 2024

Completed
3 months until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
Last Updated

January 17, 2025

Status Verified

November 1, 2024

Enrollment Period

25 days

First QC Date

November 3, 2024

Last Update Submit

January 13, 2025

Conditions

Keywords

primary hyperparathyroidismparathyroid adenomanear-infrared autofluorescenceminimally invasive parathyroidectomy

Outcome Measures

Primary Outcomes (1)

  • patterns of autofluorescence in parathyroid adenomas

    during surgery

Secondary Outcomes (3)

  • specific autofluorescence patterns correlated with the dominant cell type of a parathyroid adenoma

    during surgery

  • specific autofluorescence patterns correlated with adenoma size

    during surgery

  • specific autofluorescence patterns correlated with adenoma location

    during surgery

Interventions

The FLUOBEAM® LX apparatus consists of a camera with a built-in light emitter (750-800 nm) and detector (800-830 nm) connected to a processor with an indication-oriented software (Fluosoft®). The processor captures the emitted light, allowing display of PTG images in real time. The camera is placed in a sterile sheath and is held perpendicularly at 8 cm from the target tissue with operating lights, all background lights, and any ambient light being extinguished. The reported depth of tissue penetration of near-infrared light is limited to a maximum of 3 mm only with no observed differences between superior and inferior PTGs \[10\]. This highlights the importance of a major surgical technical point "reaching the correct plane of dissection" namely, the pre-vertebral fascia to maximize the chances of eliciting an adequate signal from parathyroid tissue. The correct application of the technology has demonstrated a success rate of signal elicitation of 90%-100% \[11\]. The ability of near-infr

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with parathyroid adenoma undergoing surgery and age \>18 years old

You may qualify if:

  • patients diagnosed with parathyroid adenoma undergoing surgery

You may not qualify if:

  • patients \<18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the Hashemite Univesity

Zarqa, Jordan

Location

Related Publications (1)

  • Bakkar S, Chorti A, Papavramidis T, Donatini G, Miccoli P. Assessing the feasibility of near infrared autofluorescence imaging in minimally-invasive video assisted parathyroidectomy and the autofluorescence signature of parathyroid adenomas. A single center surgical case series. Surg Endosc. 2025 May;39(5):2964-2972. doi: 10.1007/s00464-025-11675-8. Epub 2025 Mar 21.

MeSH Terms

Conditions

Parathyroid NeoplasmsHyperparathyroidism, Primary

Interventions

Parathyroidectomy

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesParathyroid DiseasesHyperparathyroidism

Intervention Hierarchy (Ancestors)

Endocrine Surgical ProceduresSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

November 3, 2024

First Posted

January 17, 2025

Study Start

September 20, 2024

Primary Completion

October 15, 2024

Study Completion

October 20, 2024

Last Updated

January 17, 2025

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Locations